Literature DB >> 26092398

Every reason to discontinue lithium.

Manuel E Fuentes Salgado1, Bruce Sutor, Robert C Albright, Mark A Frye.   

Abstract

Lithium as a gold standard therapy for bipolar disorder is well known to have a number of medical comorbidities that impact renal, parathyroid, and thyroid function. Despite these medical comorbidities, there remains a group of lithium-responsive lithium-treated patients who have maintained mood stability for decades. The risk/benefit ratio of end organ toxicity/mood stability must be evaluated in each individual case.

Entities:  

Year:  2014        PMID: 26092398      PMCID: PMC4477477          DOI: 10.1186/s40345-014-0012-y

Source DB:  PubMed          Journal:  Int J Bipolar Disord        ISSN: 2194-7511


  14 in total

Review 1.  Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment.

Authors:  J Kleiner; L Altshuler; V Hendrick; J M Hershman
Journal:  J Clin Psychiatry       Date:  1999-04       Impact factor: 4.384

2.  Revisiting lithium-associated hyperparathyroidism in the era of intraoperative parathyroid hormone monitoring.

Authors:  Jonathan C Hundley; Derek T Woodrum; Brian D Saunders; Gerard M Doherty; Paul G Gauger
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

3.  Quiz page August 2011: lithium-induced nephrotic syndrome.

Authors:  Abdur Baig; Adebayo S Adewale; Sonia Borra
Journal:  Am J Kidney Dis       Date:  2011-08       Impact factor: 8.860

Review 4.  Lithium toxicity profile: a systematic review and meta-analysis.

Authors:  Rebecca F McKnight; Marc Adida; Katie Budge; Sarah Stockton; Guy M Goodwin; John R Geddes
Journal:  Lancet       Date:  2012-01-20       Impact factor: 79.321

Review 5.  The science and practice of lithium therapy.

Authors:  Gin S Malhi; Michelle Tanious; Pritha Das; Michael Berk
Journal:  Aust N Z J Psychiatry       Date:  2012-03       Impact factor: 5.744

6.  Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients.

Authors:  M A Frye; K D Denicoff; A L Bryan; E E Smith-Jackson; S O Ali; D Luckenbaugh; G S Leverich; R M Post
Journal:  Am J Psychiatry       Date:  1999-12       Impact factor: 18.112

Review 7.  Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials.

Authors:  Andrea Cipriani; Heather Pretty; Keith Hawton; John R Geddes
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

8.  Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies.

Authors:  M A Frye; L Yatham; T A Ketter; J Goldberg; T Suppes; J R Calabrese; C L Bowden; E Bourne; R S Bahn; B Adams
Journal:  Acta Psychiatr Scand       Date:  2009-01-31       Impact factor: 6.392

Review 9.  Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials.

Authors:  John R Geddes; Sally Burgess; Keith Hawton; Kay Jamison; Guy M Goodwin
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

10.  The impact of modern treatment principles may have eliminated lithium-induced renal failure.

Authors:  Harald Aiff; Per-Ola Attman; Mattias Aurell; Hans Bendz; Staffan Schön; Jan Svedlund
Journal:  J Psychopharmacol       Date:  2013-12-17       Impact factor: 4.153

View more
  3 in total

1.  Lithium-Induced Hyperparathyroidism: An Ill-defined Territory.

Authors:  Vishwanath Pattan; Balwinder Singh; Sahar S Abdelmoneim; Chaitra Gopinath; Vishnu Sundaresh
Journal:  Psychopharmacol Bull       Date:  2021-06-01

2.  Does the "Silver Bullet" Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients.

Authors:  M Fornaro; B Stubbs; D De Berardis; F Iasevoli; M Solmi; N Veronese; A Carano; G Perna; A De Bartolomeis
Journal:  Clin Pract Epidemiol Ment Health       Date:  2016-12-23

Review 3.  Case Reports: Exposure to SARS-CoV-2, Acute Kidney Injury, and Lithium Toxicity.

Authors:  Melvin G McInnis; Anastasia K Yocum
Journal:  J Clin Psychopharmacol       Date:  2022-08-02       Impact factor: 3.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.